Angle up 25% on “sensational” data results
The news issued yesterday by Angle (AGL) is worthy of comment.
Angle is a specialist medtech company which has developed a technology for harvesting circulating tumour cells in blood – you can read more about Angle and its technology in AimZine’s 10 Bagger Quest article featuring the Company at http://www.investorschampion.com/aimzine/entry/the-ten-bagger-quest.
Angle’s announcement yesterday reported that the Medical University of Vienna has reported highly convincing patient data in support of the use of ANGLE’s Parsortix system in the detection of…
Previous article Next article
